Ilan Ganot is one of Solid’s founders and has served as a member of Solid’s Board of Directors since the Company’s inception in 2013. He also served as Solid’s Chief Executive Officer from 2013 to December 2022 and as Solid’s President from June 2018 to December 2022.

Ilan Ganot is currently the Chief Executive Officer and a member of the Board of Alesta Therapeutics, a biotechnology company focused on the development of innovative small molecule therapies for rare diseases.

Prior to starting Solid, Mr. Ganot spent a decade as an investment banker on Wall Street working for JPMorgan, Nomura Securities and Lehman Brothers in London, Hong Kong and New York.

Mr. Ganot is also a member of the Board of Directors of Minovia Therapeutics, a biotechnology company.

Mr. Ganot received his M.B.A. from London Business School and holds law and business degrees from the Interdisciplinary Center in Herzliya, Israel. Mr. Ganot also practiced corporate law in Israel and was a Captain in the Israeli Defense Forces.